Pharmicell Co., Ltd. vs SynCore Biotechnology Co., Ltd
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $17 M for SynCore Biotechnology Co., Ltd, 31 times as much (market caps of Aug 1, 2026 for Pharmicell Co., Ltd. and Nov 20, 2026 for SynCore Biotechnology Co., Ltd). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Pharmicell Co., Ltd. 005690.KS · #12,397 in the world | SynCore Biotechnology Co., Ltd 4192.TWO · #24,797 in the world |
|---|---|---|
| Profile | ||
| Country | 🇰🇷 South Korea | 🇹🇼 Taiwan |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $514 M | $17 M |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026 | Market cap Nov 2026 |
Questions and answers#
Which is bigger, Pharmicell Co., Ltd. or SynCore Biotechnology Co., Ltd?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $17 M for SynCore Biotechnology Co., Ltd, 31 times as much (market caps of Aug 1, 2026 for Pharmicell Co., Ltd. and Nov 20, 2026 for SynCore Biotechnology Co., Ltd). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.